Frederick Sullivan Biography and Net Worth

CFO of Senseonics Holdings, Inc. Common Stock

Rick Sullivan is the Chief Financial Officer at Senseonics, Inc.

Rick is responsible for all aspects of finance and accounting. Rick first joined Senseonics in 2011 and has served as the Vice President of Finance, Treasurer, Head of Strategy and Financial Reporting and Corporate Controller.

Prior to rejoining Senseonics in 2020, Rick served as Chief Financial Officer for RoosterBio, Inc., a privately held regenerative medicine company and as the Principal of Hike Financial, LLC, an advisory firm that provides financial, accounting and administrative services to early growth, life sciences and technology companies.

Rick received his M.B.A. from the University of Maryland, Robert H. Smith School of Business, his B.S. in accounting from Salisbury University, Perdue School of Business. Rick maintains an active CPA license in the state of Maryland.

What is Frederick T. Sullivan's net worth?: The estimated net worth of Frederick T. Sullivan is at least $887.05 thousand as of November 7th, 2025. Mr. Sullivan owns 157,028 shares of Senseonics Holdings, Inc. Common Stock stock worth more than $887,051 as of March 13th. This net worth approximation does not reflect any other assets that Mr. Sullivan may own. Learn More about Frederick T. Sullivan's net worth.
How do I contact Frederick T. Sullivan?: The corporate mailing address for Mr. Sullivan and other Senseonics Holdings, Inc. Common Stock executives is 20451 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876. Senseonics Holdings, Inc. Common Stock can also be reached via phone at (301) 515-7260 and via email at [email protected]. Learn More on Frederick T. Sullivan's contact information.
Has Frederick T. Sullivan been buying or selling shares of Senseonics Holdings, Inc. Common Stock?: Frederick T. Sullivan has not been actively trading shares of Senseonics Holdings, Inc. Common Stock within the last three months. Most recently, on Friday, November 7th, Frederick T. Sullivan bought 5,415 shares of Senseonics Holdings, Inc. Common Stock stock. The stock was acquired at an average cost of $5.88 per share, with a total value of $31,840.20. Following the completion of the transaction, the chief financial officer now directly owns 157,028 shares of the company's stock, valued at $923,324.64. Learn More on Frederick T. Sullivan's trading history.
Who are Senseonics Holdings, Inc. Common Stock's active insiders?: Senseonics Holdings, Inc. Common Stock's insider roster includes Timothy Goodnow (CEO), Sharon Larkin (Director), Douglas Roeder (Director), and Frederick Sullivan (CFO). Learn More on Senseonics Holdings, Inc. Common Stock's active insiders.
Are insiders buying or selling shares of Senseonics Holdings, Inc. Common Stock?: In the last twelve months, Senseonics Holdings, Inc. Common Stock insiders bought shares 3 times. They purchased a total of 30,415 shares worth more than $184,790.20. The most recent insider tranaction occured on November, 10th when Director Edelman Steven bought 10,000 shares worth more than $65,500.00. Insiders at Senseonics Holdings, Inc. Common Stock own 3.6% of the company. Learn More about insider trades at Senseonics Holdings, Inc. Common Stock.
Information on this page was last updated on 11/10/2025.

Frederick T. Sullivan Insider Trading History at Senseonics Holdings, Inc. Common Stock

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/7/2025	Buy	5,415	$5.88	$31,840.20	157,028
12/12/2024	Buy	6,246	$7.60	$47,469.60	123,942

Frederick T. Sullivan Buying and Selling Activity at Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc. Common Stock Company Overview

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Today's Range

Now: $5.64

$5.58

$5.93

50 Day Range

MA: N/A

2 Week Range

Now: $5.64

$5.25

$15.74

Volume

455,894 shs

Average Volume

504,173 shs

Market Capitalization

$235.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9